Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.56 -1.19 (-3.24%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	13,617,243
Open	37.80
Bid (Size)	35.51 (900)
Ask (Size)	35.53 (1,600)
Prev. Close	36.75
Today's Range	35.10 - 39.05
52wk Range	24.88 - 43.15
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MarketBeat Week in Review – 09/21 - 09/25 ↗

September 26, 2026

A weekly roundup of MarketBeat analysis on volatile markets, oil, bond rates, AI stocks, dividend picks, and earnings outlooks, covering companies from NVIDIA to Tesla and Qualcomm.

Via MarketBeat

Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy? ↗

September 25, 2026

The biotech player could eventually rival big pharma companies.

Via The Motley Fool

Performance

YTD	+0.4%	+0.4%
1 Month	+5.0%	+5.0%
3 Month	-10.1%	-10.1%
6 Month	+18.9%	+18.9%
1 Year	+39.1%	+39.1%

More News

Here's Why Viking Therapeutics Shares Slumped Today ↗

September 24, 2026

Via The Motley Fool

Viking's Obesity Edge May Be Staying Power, Not Weight Loss ↗

September 23, 2026

Via MarketBeat

Why Viking Therapeutics Stock Skyrocketed on Tuesday ↗

September 23, 2026

Via The Motley Fool

Which stocks are experiencing notable movement on Tuesday? ↗

September 22, 2026

Via Chartmill

What's going on in today's session ↗

September 22, 2026

Via Chartmill

Gapping stocks in Tuesday's session ↗

September 22, 2026

Via Chartmill

Viking Therapeutics’ VK2735 Shows Strong Weight-Loss Retention With Monthly Dosing ↗

September 22, 2026

Via MarketBeat

Tuesday's pre-market session: top gainers and losers ↗

September 22, 2026

Via Chartmill

Wall Street Sees a Huge Rebound for Viking Therapeutics. Here's Why Analysts Are So Optimistic. ↗

September 17, 2026

Via The Motley Fool

Viking Therapeutics Advances VK2735 Obesity Drug Into Phase 3 After 15% Weight Loss ↗

September 14, 2026

Via MarketBeat

Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September ↗

September 11, 2026

Via The Motley Fool

Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

September 10, 2026

Via The Motley Fool

Analysts Have a $92 Target on Viking Therapeutics. Here's What Has to Go Right to Get There. ↗

September 10, 2026

Via The Motley Fool

Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case. ↗

September 05, 2026

Via The Motley Fool

3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're Wrong ↗

September 03, 2026

Via The Motley Fool

Viking Therapeutics Stock Is Down 66% From Its Peak. Here's What Comes Next. ↗

August 30, 2026

Via The Motley Fool

Viking Therapeutics Has $502 Million in Cash and 1 Big Catalyst Left in 2026 -- Is That Enough? ↗

August 27, 2026

Via The Motley Fool

2 GLP-1 Stocks That Could Double Your Money by 2031 ↗

August 16, 2026

Via The Motley Fool

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics? ↗

August 08, 2026

Via The Motley Fool

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished ↗

August 06, 2026

Via The Motley Fool

Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target ↗

July 30, 2026

Via The Motley Fool

Viking Therapeutics Stock Moves Lower: What's Going On? ↗

July 30, 2026

Via Benzinga

Viking Therapeutics Q2 Earnings Call Highlights ↗

July 29, 2026

Via MarketBeat

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?

Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Viking Therapeutics, Inc. - Common Stock trade on?

Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?

The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market

What is the current price of Viking Therapeutics, Inc. - Common Stock?

The current price of Viking Therapeutics, Inc. - Common Stock is 35.56

When was Viking Therapeutics, Inc. - Common Stock last traded?

The last trade of Viking Therapeutics, Inc. - Common Stock was at 09/25/26 04:00 PM ET

What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?

The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.54B

How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?

Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.